Company / Shareholders' Equity
Imunon, Inc. Shareholders' Equity History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$29.3M
FY2023
5-year range
$14.6M / $55.8M
FY2019-FY2023
Trend
-47.4%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $19M to $29M over the past 2 years.
Based on SEC 10-K filings.
$29M in FY2023 with a 5-year CAGR of +1.9%.
Improved from $19M to $29M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- +1.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +1.9%, indicating consistent growth.
- In FY2023, shareholders' equity decreased 47.4% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
- Lowest shareholders' equity in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $29.3M | -47.4% |
| FY2022 | $55.8M | +199.8% |
| FY2021 | $18.6M | +27.8% |
| FY2020 | $14.6M | -30.2% |
| FY2019 | $20.9M | -21.9% |
| FY2018 | $26.7M | -18.6% |
| FY2015 | $32.8M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026